Cardiometabolic risks of SARS-CoV-2 hospitalization using Mendelian Randomization
Abstract Many cardiometabolic conditions have demonstrated associative evidence with COVID-19 hospitalization risk. However, the observational designs of the studies in which these associations are observed preclude causal inferences of hospitalization risk. Mendelian Randomization (MR) is an altern...
Guardado en:
Autores principales: | Noah Lorincz-Comi, Xiaofeng Zhu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/53192822b200446b81806a74013da393 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study.
por: Joanna Lankester, et al.
Publicado: (2021) -
Mendelian randomization study of maternal influences on birthweight and future cardiometabolic risk in the HUNT cohort
por: Gunn-Helen Moen, et al.
Publicado: (2020) -
The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis.
por: Tove Fall, et al.
Publicado: (2013) -
Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
por: Samir Andrade Mendonça, et al.
Publicado: (2021) -
Coronavirus (SARS-CoV-2): Preventions, keys to diagnosis and treatment of SARS-CoV-2
por: Kuldeep Singh Patel, et al.
Publicado: (2020)